跳至主要内容
临床试验/NCT02648958
NCT02648958已完成不适用

Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Unilateral Total Knee Replacement - a Randomized, Controlled Trial

Yonsei University1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2016年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
68
试验地点
1
主要终点
changes of malondialdehyde (μmol/L)

研究概览

简要总结

Ischemia reperfusion injury causes the release of free oxygen radicals. The selective alpha2-receptor agonist, dexmedetomidine, has an inhibitory effect on inflammatory responses during ischemic injury. The aim of this study is to evaluate the effect of dexmedetomidine on inflammatory responses during ischemia-reperfusion injury in skeletal muscle.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society Anesthesiologists classification I-III

排除标准

  • use of antioxidants clinically significant cardiovascular, renal, or hepatic diseases heart block greater than the first degree

研究组 & 干预措施

Control group

Placebo Comparator

The control group received saline instead of dexmedetomidine.

干预措施: normal saline (Drug)

Dexmedetomidine group

Experimental

The dexmedetomidine group received the dexmedetomidine.

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

changes of malondialdehyde (μmol/L)

时间窗: up to 1 day

次要结局

  • changes of interleukin-6 (pg/ml)(up to 1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验